» Articles » PMID: 38893554

Unveiling Conformational States of CDK6 Caused by Binding of Vcyclin Protein and Inhibitor by Combining Gaussian Accelerated Molecular Dynamics and Deep Learning

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2024 Jun 19
PMID 38893554
Authors
Affiliations
Soon will be listed here.
Abstract

CDK6 plays a key role in the regulation of the cell cycle and is considered a crucial target for cancer therapy. In this work, conformational transitions of CDK6 were identified by using Gaussian accelerated molecular dynamics (GaMD), deep learning (DL), and free energy landscapes (FELs). DL finds that the binding pocket as well as the T-loop binding to the Vcyclin protein are involved in obvious differences of conformation contacts. This result suggests that the binding pocket of inhibitors (LQQ and AP9) and the binding interface of CDK6 to the Vcyclin protein play a key role in the function of CDK6. The analyses of FELs reveal that the binding pocket and the T-loop of CDK6 have disordered states. The results from principal component analysis (PCA) indicate that the binding of the Vcyclin protein affects the fluctuation behavior of the T-loop in CDK6. Our QM/MM-GBSA calculations suggest that the binding ability of LQQ to CDK6 is stronger than AP9 with or without the binding of the Vcyclin protein. Interaction networks of inhibitors with CDK6 were analyzed and the results reveal that LQQ contributes more hydrogen binding interactions (HBIs) and hot interaction spots with CDK6. In addition, the binding pocket endures flexibility changes from opening to closing states and the Vcyclin protein plays an important role in the stabilizing conformation of the T-loop. We anticipate that this work could provide useful information for further understanding the function of CDK6 and developing new promising inhibitors targeting CDK6.

Citing Articles

Binding Mechanism of Inhibitors to CDK6 Deciphered by Multiple Independent Molecular Dynamics Simulations and Free Energy Predictions.

Wang L, Wang Y, Zhang L, Zhao J, Wu S, Yang Z Molecules. 2025; 30(5).

PMID: 40076203 PMC: 11901890. DOI: 10.3390/molecules30050979.


Identifying Inhibitor-SARS-CoV2-3CL Binding Mechanism Through Molecular Docking, GaMD Simulations, Correlation Network Analysis and MM-GBSA Calculations.

Chen J, Wang J, Yang W, Zhao L, Xu X Molecules. 2025; 30(4).

PMID: 40005117 PMC: 11857935. DOI: 10.3390/molecules30040805.


Unveiling Allosteric Regulation and Binding Mechanism of BRD9 through Molecular Dynamics Simulations and Markov Modeling.

Wang B, Wang J, Yang W, Zhao L, Wei B, Chen J Molecules. 2024; 29(15).

PMID: 39124901 PMC: 11314499. DOI: 10.3390/molecules29153496.


Insights into the Interaction Mechanisms of Peptide and Non-Peptide Inhibitors with MDM2 Using Gaussian-Accelerated Molecular Dynamics Simulations and Deep Learning.

Yang W, Wang J, Zhao L, Chen J Molecules. 2024; 29(14).

PMID: 39064955 PMC: 11279683. DOI: 10.3390/molecules29143377.

References
1.
Chen J, Zhang S, Wang W, Pang L, Zhang Q, Liu X . Mutation-Induced Impacts on the Switch Transformations of the GDP- and GTP-Bound K-Ras: Insights from Multiple Replica Gaussian Accelerated Molecular Dynamics and Free Energy Analysis. J Chem Inf Model. 2021; 61(4):1954-1969. DOI: 10.1021/acs.jcim.0c01470. View

2.
Mahony D, Parry D, Lees E . Active cdk6 complexes are predominantly nuclear and represent only a minority of the cdk6 in T cells. Oncogene. 1998; 16(5):603-11. DOI: 10.1038/sj.onc.1201570. View

3.
Harvey M, Giupponi G, De Fabritiis G . ACEMD: Accelerating Biomolecular Dynamics in the Microsecond Time Scale. J Chem Theory Comput. 2015; 5(6):1632-9. DOI: 10.1021/ct9000685. View

4.
Russo A, Tong L, Lee J, Jeffrey P, Pavletich N . Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature. 1998; 395(6699):237-43. DOI: 10.1038/26155. View

5.
Onufriev A, Bashford D, Case D . Exploring protein native states and large-scale conformational changes with a modified generalized born model. Proteins. 2004; 55(2):383-94. DOI: 10.1002/prot.20033. View